Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial
Karim Fizazi, Ken Herrmann, Bernd J. Krause, Kambiz Rahbar, Kim N., Michael J. Morris, Oliver Sartor, Scott T. Tagawa, A. Tuba Kendi, Nicholas J. Vogelzang, Jérémie Calais, James Nagarajah, Xiao X. Wei, Vadim S. Koshkin, Jean‐Mathieu Beauregard, Brian Chang, Ray Ghouse, Michelle DeSilvio, Richard A. Messmann, Johann S. de Bono
Topics & Concepts
MedicineProstate cancerGlutamate carboxypeptidase IIRadioligandQuality of life (healthcare)OncologyInternal medicineLutetiumCancerNursingReceptorOrganic chemistryOxideChemistryYttriumProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Diagnosis and Treatment